North America Pharmacokinetics Services Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)

No. of Pages: 87    |    Report Code: BMIRE00030931    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Pharmacokinetics Services Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Pharmacokinetics Services Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Pharmacokinetics Services Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Chronic and Infectious Diseases Drives the Pharmacokinetics Services Market
5.2 Market Opportunities
  • 5.2.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics is the opportinity in the Pharmacokinetics Services Market
5.3 Future Trends
  • 5.3.1 Expanding Range of Application of Pharmacokinetic Studies Drives the Pharmacokinetics Services Market
5.4 Impact of Drivers and Restraints

6. North America Pharmacokinetics Services Market Regional Analysis

6.1 North America Pharmacokinetics Services Market Overview
6.2 North America Pharmacokinetics Services Market Revenue 2021-2031 (US$ Million)
6.3 North America Pharmacokinetics Services Market Forecast Analysis

7. North America Pharmacokinetics Services Market Analysis – by Drug Type

7.1 Small Molecule
  • 7.1.1 Overview
  • 7.1.2 Small Molecule: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Large Molecule
  • 7.2.1 Overview
  • 7.2.2 Large Molecule: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Vaccines
  • 7.3.1 Overview
  • 7.3.2 Vaccines: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Pharmacokinetics Services Market Analysis – by Service Type

8.1 Pre-Clinical ADME and Human Studies
  • 8.1.1 Overview
  • 8.1.2 Pre-Clinical ADME and Human Studies: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.2 PK/PD Analysis and Reporting
  • 8.2.1 Overview
  • 8.2.2 PK/PD Analysis and Reporting: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Dosing Simulations
  • 8.3.1 Overview
  • 8.3.2 Dosing Simulations: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Risk Analysis
  • 8.4.1 Overview
  • 8.4.2 Risk Analysis: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

9. North America Pharmacokinetics Services Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies
  • 9.1.1 Overview
  • 9.1.2 Risk Analysis: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Contract Research Organization
  • 9.2.1 Overview
  • 9.2.2 Risk Analysis: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

10. North America Pharmacokinetics Services Market – North America Analysis

10.1 North America
  • 10.1.1 North America Pharmacokinetics Services Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.1.1.1 North America Pharmacokinetics Services Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.1.1 US: North America Pharmacokinetics Services Market Breakdown, by Drug Type
    • 10.1.1.1.2 US: North America Pharmacokinetics Services Market Breakdown, by Service Type
    • 10.1.1.1.3 US: North America Pharmacokinetics Services Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.2.1 Canada: North America Pharmacokinetics Services Market Breakdown, by Drug Type
    • 10.1.1.2.2 Canada: North America Pharmacokinetics Services Market Breakdown, by Service Type
    • 10.1.1.2.3 Canada: North America Pharmacokinetics Services Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Pharmacokinetics Services Market Breakdown, by Drug Type
    • 10.1.1.3.2 Mexico : North America Pharmacokinetics Services Market Breakdown, by Service Type
    • 10.1.1.3.3 Mexico : North America Pharmacokinetics Services Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Pharmacokinetics Services Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Charles River Laboratories International Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Eurofins Scientific SE
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Evotec SE
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Certara Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Parexel International Corp
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Allucent
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 PACIFIC BIOLABS
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 SGS SA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Charles River Laboratories International Inc
  2. Eurofins Scientific SE
  3. Evotec SE
  4. Certara Inc.
  5. Parexel International Corp
  6. Thermo Fisher Scientific Inc.
  7. Allucent
  8. PACIFIC BIOLABS
  9. SGS SA
north-america-pharmacokinetics-services-market